Results 121 to 130 of about 609 (139)

Pachychoroid neovasculopathy: A comparative review on pathology, clinical features, and therapy

European Journal of Ophthalmology, 2021
There have been major changes in our understanding of choroidal diseases in the last decade owing to multiple retinal and choroidal imaging related advances. A major conceptual pivot is establishment of pachychoroid and its spectrum of clinical disorders: pachychoroid pigment epitheliopathy, central serous chorioretinopathy, pachychoroid ...
Pradeep Sagar, Preetkanwar Singh Sodhi, Sangeeta Roy, Brijesh Takkar, Shorya Vardhan Azad   +4 more
openaire   +2 more sources

Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy

Journal of Ocular Pharmacology and Therapeutics, 2019
Abstract Purpose: To compare the effectiveness of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for pachychoroid neovasculopathy and neovascular age-related macular degeneration (AMD). Methods:
Han Joo Cho, Tae Kwann Park
exaly   +3 more sources

Subretinal Hyperreflective Material, Atrophy, and Intraretinal Fluid in Pachychoroid Neovasculopathy

American Journal of Ophthalmology
To assess the association between subretinal hyperreflective material (SHRM), atrophy, and intraretinal fluid (IRF) in pachychoroid neovasculopathy (PNV).Retrospective observational study.A total of 120 eyes diagnosed with PNV and treated with antivascular endothelial growth factor for more than 1 year.Central macular thickness (CMT), best-corrected ...
Jiwon Baek, Ho Ra, Seung Hoon Lee, Chui Ming Gemmy Cheung, Won Ki Lee   +4 more
openaire   +2 more sources

Pachychoroid Neovasculopathy, Intravitreal Injection, and Implications for Aeromedical Decision Making

Aerospace Medicine and Human Performance
BACKGROUND: Optimal visual function is essential in aviation to ensure flight safety and mission effectiveness. Pachychoroid neovasculopathy is a relatively recently recognized clinical entity of choroidal neovascularization, belonging to the pachychoroid spectrum, for which intravitreal therapy (IVT) is the ...
Wei Yun Lily, Yang, Isaac Wei Jie, Chay, Hou Boon, Lim, Marcus Chiang Lee, Tan, Brian, See, Jason Weizheng, Low   +5 more
openaire   +2 more sources

Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy

Graefe's Archive for Clinical and Experimental Ophthalmology
Long-term results of photodynamic therapy (PDT) combined with vascular endothelial growth factor (VEGF) inhibitors for pachychoroid neovasculopathy (PNV) are not yet clear.This study is a retrospective, observational case series. We retrospectively examined untreated PNV cases (22 cases, 22 eyes, mean age of 71.0 years) who underwent PDT therapy in ...
Ryo Obata, Kohdai Kitamoto, Kohei Ueda   +2 more
exaly   +3 more sources

Pachychoroid neovasculopathy.

Archivos de la Sociedad Espanola de Oftalmologia, 2021
I A, Placinta, R, Castro-Seco, J, Díaz-Cascajosa   +2 more
openaire   +1 more source

Two-Year Results of a Treat and Extend Regimen with Aflibercept in Caucasian Patients with Pachychoroid Neovasculopathy

Seminars in Ophthalmology, 2023
Lidia Remoli Sargues, Clara Monferrer Adsuara   +1 more
exaly  

Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy

Ophthalmology Retina, 2022
Jakob Siedlecki, Julian E Klaas, Ben Asani   +2 more
exaly  

A comparative study of type 1 neovascularization: Neovascular age-related macular degeneration versus pachychoroid neovasculopathy

European Journal of Ophthalmology, 2022
Muhammed Altinisik, Emin Kurt, Ozcan Kayikcioglu   +2 more
exaly  

Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy

Cutaneous and Ocular Toxicology, 2022
Buḡra Karasu, Mert Kaskal, Aslan Aykut   +2 more
exaly